Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.
Akiska YM, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender VD, Castelo-Soccio L, Cotsarelis G, Craiglow BG, Desai NS, Doche I, Duque-Estrada B, Elston DM, Goh C, Goldberg LJ, Grimalt R, Jabbari A, Jolliffe V, King BA, LaSenna C, Lenzy Y, Lester JC, Lortkipanidze N, Lo Sicco KI, McMichael A, Meah N, Mesinkovska N, Miteva M, Mostaghimi A, Ovcharenko Y, Piliang M, Piraccini BM, Rakowska A, Salkey KS, Schmidt A, Shapiro J, Sibbald C, Sinclair R, Suchonwanit P, Taylor S, Tosti A, Vañó-Galván S, Wall DR, Fu JM. Akiska YM, et al. Among authors: sinclair r. JAMA Dermatol. 2024 Nov 20. doi: 10.1001/jamadermatol.2024.4593. Online ahead of print. JAMA Dermatol. 2024. PMID: 39565602
Rosacea Fulminans following Initiation of Deucravacitinib.
Thomas M, Paranjape M, Sinclair R. Thomas M, et al. Among authors: sinclair r. Clin Exp Dermatol. 2024 Nov 15:llae495. doi: 10.1093/ced/llae495. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 39545490 No abstract available.
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial.
Piliang M, Lynde C, King B, Mirmirani P, Sinclair R, Senna M, Forman S, Bordone L, De La Cueva Dobao P, Wolk R, Zwillich SH, Tran H, Wajsbrot D, Ahmed HM, Takiya L. Piliang M, et al. Among authors: sinclair r. J Am Acad Dermatol. 2024 Oct 17:S0190-9622(24)03006-8. doi: 10.1016/j.jaad.2024.09.064. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39423930 Free article.
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
Mesinkovska N, King B, Zhang X, Guttman-Yassky E, Magnolo N, Sinclair R, Mizuashi M, Shapiro J, Peeva E, Banerjee A, Takiya L, Cox LA, Wajsbrot D, Kerkmann U, Law E, Wolk R, Schaefer G. Mesinkovska N, et al. Among authors: sinclair r. J Dermatol. 2024 Nov;51(11):1414-1424. doi: 10.1111/1346-8138.17442. Epub 2024 Sep 27. J Dermatol. 2024. PMID: 39328096 Clinical Trial.
Re: Schulte et al., "An urgent call to address work-related psychosocial hazards and improve worker well-being": It's time to develop a national regulation regarding work-related psychosocial hazards.
Dobson M, Faghri P, Landsbergis P, LeGrande D, Nobrega S, Punnett L, Rice S, Schnall P, Bahruth A, Baker D, Baron S, Blustein D, Cavallari J, Cherniack M, Fazen L, Goldstein-Gelb M, Gomez-Ortiz V, González-Morales MG, Hammer LB, Hughes JC, LaMontagne AD, Martinez J, Namie G, Persaud E, Pratap P, Rodriguez M, Rosen J, Rosskam E, Rospenda KM, Sallman S, Sembajwe G, Sinclair R, Stock L, Wrightson K, Yamada D, Yang LQ, Yelin E, Zelnick J, Zoeckler J. Dobson M, et al. Among authors: sinclair r. Am J Ind Med. 2024 Nov;67(11):1050-1052. doi: 10.1002/ajim.23657. Epub 2024 Sep 20. Am J Ind Med. 2024. PMID: 39302666 No abstract available.
973 results